Pembrolizumab Plus Vorinostat a Potential Combo for Lung Cancer - DocWire News
Pembrolizumab Plus Vorinostat a Potential Combo for Lung Cancer DocWire News
A phase I/Ib study published in Clinical Cancer Research found that treatment with the immune checkpoint inhibitor (ICI) pembrolizumab plus the histone.
Comments
Post a Comment